Herborium Group, Inc.

HBRM

US42703A2087

Biotechnology & Medical Research

Market Closed - OTC Markets Other stock markets 11:42:40 2024-05-17 EDT			5-day change	1st Jan Change
0.0001 ^USD	0.00%		0.00%	+9,900.00%

2021	Herborium Group, Inc. Moves into Manufacturing Phase for Its New Protein Bars	CI
2021	Herborium Group Progresses with Distribution Agreements for Acnease and Cosmeceuticals to Take Advantage of $8 Billion French Cosmetic Market	CI

Herborium Group, Inc. will Change its Ticker to HBRMD from HBRM.D

January 27, 2014 at 12:00 am

Effective January 27, 2014, Herborium Group, Inc. will change its Pink Sheets LLC stock ticker symbol to HBRMD from HBRM.D.

Latest news about Herborium Group, Inc.

Herborium Group, Inc. Moves into Manufacturing Phase for Its New Protein Bars	21-10-07	CI
Herborium Group Progresses with Distribution Agreements for Acnease and Cosmeceuticals to Take Advantage of $8 Billion French Cosmetic Market	21-09-21	CI
Herborium to Develop Proprietary Protein Bar with Unique Skin Benefits and Weight Management Properties	21-06-28	CI
Herborium Group, Inc. Announces Joining of Ashok N. Vasvani to Herborium Team	21-06-23	CI
Herborium Group, Inc. Moves to the Next Level in Building Disruptive, Integrated, Natural Medicine Content and Commerce Platform	21-03-23	CI
Herborium Group, Inc. Announces Unique Herbal Acne Treatment AcnEase to Enter the Fastest Growing Asia Pacific Market	21-03-04	CI
Herborium Group, Inc. Introduces Proprietary Two- In- One Biodegradable, Multi-Use Facial Mask	21-02-08	CI
Herborium Group, Inc. Reports Sales Results for the Second Quarter and Six Months of 2015	15-06-25	CI
Herborium Group, Inc. Announces Earnings Results for the First Quarter of 2015	15-04-16	CI
Herborium Group, Inc. Announces Sales Results for the First Quarter of Fiscal 2015	15-03-31	CI
Herborium Group, Inc. Announces Earnings Results for the Full Year 2014	15-03-02	CI
Herborium(R) Group, Inc. Announces Earnings Results for the Third Quarter of 2014 and Sales Results for the First Three Quarters of 2014	14-10-16	CI
Herborium Group, Inc. Reports Sales Results for the Second Quarter and Six Months Ended May 31, 2014	14-07-17	CI
Herborium Group, Inc. Reports Sales Results for the First Quarter of 2014	14-03-27	CI
Herborium Group, Inc. Announces Sales Results for the Year 2013	14-03-10	CI
Herborium Group, Inc. will Change its Ticker to HBRM from HBRM.D	14-02-25	CI
Herborium Group, Inc. will Change its Ticker to HBRMD from HBRM.D	14-01-27	CI
Herborium Seeks Acquisitions	14-01-27	CI
Herborium Group, Inc. Launches Two New Botanical Therapeutics(R): Lasting Pleasure(R) for Women and Lasting Power(R) for Men	13-11-26	CI
Tranche Update on Herborium Group, Inc.'s Equity Buyback Plan announced on April 23, 2012	13-04-14	CI
Tranche Update on Herborium Group, Inc.'s Equity Buyback Plan announced on April 23, 2012	13-02-27	CI
China Health Resource, Inc. cancelled the acquisition of Herborium Group Inc (OTC PINKSHEETS:HBRM) on February 21, 2013.	13-02-20	CI
Herborium Group, Inc. Completes Manufacturing of Sexual Health Formulas to Hit the Market in March 2013	13-02-14	CI
Herborium Group, Inc. Revised Revenue Guidance for 2013	13-01-29	CI
Herborium Group, Inc.'s Equity Buyback announced on April 23, 2012 has expired with the repurchase of 0 shares, representing 0% for $0 million.	12-12-30	CI

Herborium Group, Inc. is a developer, licensor and marketer of herbal ingredient-based medicines and wellness products. The Company's flagship product, AcnEase is an herbal, oral treatment for patients with acne or rosacea. The Company serves clients worldwide. It is engaged in the development of a series of the artificial intelligence (AI)-based content products related to dermatological and beauty space. In addition to AcnEase, the Company has secured a pipeline of product candidates. The products include protein skin bar and adjunct cutting age skincare products based on stem cell technology. it is also ready for commercialization of new products line of natural sexual health and performance enhancing products for men and women. The Company owns all formulations for its proprietary products.

Sector

Biotechnology & Medical Research

More about the company

Sector Bio Therapeutic Drugs

	1st Jan change	Capi.
HERBORIUM GROUP, INC.	+9,900.00%	1.09M
VERTEX PHARMACEUTICALS INCORPORATED	+9.42%	115B
REGENERON PHARMACEUTICALS, INC.	+11.84%	106B
BIONTECH SE	-14.15%	21.84B
ARGENX SE	-1.05%	21.96B
GENMAB A/S	-5.29%	19.21B
WUXI APPTEC CO., LTD.	-38.29%	17.71B
BEIGENE, LTD.	-4.16%	18.08B
NEUROCRINE BIOSCIENCES, INC.	+7.99%	14.32B
SAREPTA THERAPEUTICS, INC.	+36.24%	12.42B

Bio Therapeutic Drugs